Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Chagas Disease

5,8,11,14-eicosatetraynoic acid has been researched along with Chagas Disease in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Bracco, MM1
Sterin-Borda, L1
Fink, S1
Finiasz, M1
Borda, E1

Other Studies

1 other study available for 5,8,11,14-eicosatetraynoic acid and Chagas Disease

ArticleYear
Stimulatory effect of lymphocytes from Chagas' patients on spontaneously beating rat atria.
    Clinical and experimental immunology, 1984, Volume: 55, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Catechols; Chagas Cardiomyopathy; Chagas Disease;

1984